Medtronic plc (NYSE:MDT) 2024 Wells Fargo Healthcare Conference September 4, 2024 11:35 AM ET Company Participants Geoff Martha - Chairman & CEO Conference Call Participants Larry Biegelsen - Wells Fargo Larry Biegelsen Good afternoon or good morning, and it’s about to be good afternoon and welcome to the 2024 Wells Fargo Healthcare Conference. Thank you for helping make this our largest healthcare conference yet. I'm Larry Biegelsen, the medical device analyst at Wells Fargo, and I'm thrilled to host this ...

Medtronic plc (NYSE:MDT) 2024 Wells Fargo Healthcare Conference September 4, 2024 11:35 AM ET Company Participants Geoff Martha - Chairman & CEO Conference Call Participants Larry Biegelsen - Wells Fargo Larry Biegelsen Good afternoon or good morning, and it’s about to be good afternoon and welcome to the 2024 Wells Fargo Healthcare Conference. Thank you for helping make this our largest healthcare conference yet. I'm Larry Biegelsen, the medical device analyst at Wells Fargo, and I'm thrilled to host this ...

It might not be the most exciting business, but it has other things going its way.Medical device giant Medtronic (MDT 0.44%) has been somewhat of a stock market laggard over the past five years, partly due to pandemic-related disruptions. Even beyond this global issue, the healthcare giant has had trouble growing its revenue and earnings fast enough to excite investors. However, if its latest earnings report is any indication, Medtronic seems to be moving in the right direction, at least within what will ar ...

GALWAY, Ireland, Aug. 27, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 2024 Wells Fargo Healthcare Conference on Wednesday, September 4, 2024.Geoff Martha, Medtronic chairman and chief executive officer, will answer questions on the medtech industry and on the company beginning at approximately 11:55 a.m. EDT (12:55 p.m. CDT).A live webcast of the Q&A session will be available on September 4, 2024, by clicking on the Even ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 26, 2024 ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. For the transition period from __________ to __________ Commission File Number 001-36820 ® Medtronic plc (Exact name of registrant as specified in its charter) Ireland 98-1183488 (State of incorporation) (I.R.S. ...

This MedTech leader is back on track with profitable growth.Medtronic (MDT 0.59%)posted first-quarter earnings (for the period ended on June 30) that exceeded the average of Wall Street estimates. The results were strong enough for the medical technologies giant to raise its full-year profit forecast.Investors should welcome the improved outlook, which could signal the start of a bigger turnaround for the company. Medtronic stock rallied on the report but is still down more than 30% from its record high set ...

WolterkMedtronic (NYSE:MDT) has faced several challenges in the past decade. Some were probably because of poor focus and lack of innovation, while others, like COVID-19, were out of their control. Consequently, the share price has languished after peaking in mid-2021. It currently trades at levels in 2018. However, Medtronic is a market leader with solid competitive advantages. Also, performance has recently improved. The stock is undervalued and possesses a nice yield. I expect the dividend streak to ...

PITTSBURGH, Aug. 23, 2024 /PRNewswire/ -- Federated Hermes, Inc. (NYSE: FHI), a global leader in active investing, today announced that the Federated Hermes ETF Trust, on behalf of its portfolio, Federated Hermes MDT Large Cap Growth ETF (NYSE: FLCG), which seeks long-term capital appreciation by investing primarily in common stocks of large capitalization (large-cap) U.S. companies with higher forecasted growth values relative to the market, has obtained approval by majority shareholder consent action to c ...

Medtronic TodayMDTMedtronic$87.86 +0.32 (+0.37%) 52-Week Range$68.84▼$89.24Dividend Yield3.19%P/E Ratio31.95Price Target$91.50Add to WatchlistShares of medical device manufacturer Medtronic PLC NYSE: MDT are down about 35% from their highs of roughly three years ago, but promising results from the company's first quarter of fiscal 2025, which ended July 26, could help to drive renewed upward momentum. Specifically, Medtronic's diabetes and neuromodulation products may be poised for breakout growth, and the ...

This photo taken on Nov. 8, 2023 shows a booth of Medtronic at the 6th China International Import ... [+] Expo CIIE in east China's Shanghai. (Photo by Wang Xiang/Xinhua via Getty Images)Xinhua News Agency via Getty ImagesMedtronic (NYSE: MDT) recently reported its Q1 fiscal 2025 results (fiscal ends in April), with revenues and earnings exceeding our estimates. The company reported revenue of $7.9 billion and adjusted earnings of $1.23 per share, compared to our estimates of $7.9 billion and $1.21, respect ...